Abstract:Gram-positive Streptomyces bacteria produce thousands of bioactive secondary metabolites, including antibiotics. To systematically investigate genes affecting secondary metabolism, we developed a hyperactive transposase-based Tn5 transposition system and employed it to mutagenize the model species Streptomyces coelicolor, leading to the identification of 51,443 transposition insertions. These insertions were distributed randomly along the chromosome except for some preferred regions associated with relatively low GC content in the chromosomal core. The base composition of the insertion site and its flanking sequences compiled from the 51,443 insertions implied a 19-bp expanded target site surrounding the insertion site, with a slight nucleic acid base preference in some positions, suggesting a relative randomness of Tn5 transposition targeting in the high-GC Streptomyces genome. From the mutagenesis library, 724 mutants involving 365 genes had altered levels of production of the tripyrrole antibiotic undecylprodigiosin (RED), including 17 genes in the RED biosynthetic gene cluster. Genetic complementation revealed that most of the insertions (more than two-thirds) were responsible for the changed antibiotic production. Genes associated with branched-chain amino acid biosynthesis, DNA metabolism, and protein modification affected RED production, and genes involved in signaling, stress, and transcriptional regulation were overrepresented. Some insertions caused dramatic changes in RED production, identifying future targets for strain improvement.IMPORTANCE High-GC Gram-positive streptomycetes and related actinomycetes have provided more than 100 clinical drugs used as antibiotics, immunosuppressants, and antitumor drugs. Their genomes harbor biosynthetic genes for many more unknown compounds with potential as future drugs. Here we developed a useful genome-wide mutagenesis tool based on the transposon Tn5 for the study of secondary metabolism and its regulation. Using Streptomyces coelicolor as a model strain, we found that chromosomal insertion was relatively random, except at some hot spots, though there was evidence of a slightly preferred 19-bp target site. We then used prodiginine production as a model to systematically survey genes affecting antibiotic biosynthesis, providing a global view of antibiotic regulation. The analysis revealed 348 genes that modulate antibiotic production, among which more than half act to reduce production. These might be valuable targets in future investigations of regulatory mechanisms, for strain improvement, and for the activation of silent biosynthetic gene clusters.

Pan-Genome of the Genus Streptomyces and Prioritization of Biosynthetic Gene Clusters With Potential to Produce Antibiotic Compounds

Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria

[Advances of Genome and Secondary Metabolism in Streptomyces].

Thirty complete Streptomyces genome sequences for mining novel secondary metabolite biosynthetic gene clusters

Comparative Genomics with Evolutionary Lineage in Streptomyces Bacteria Reveals High Biosynthetic Potentials

Complete genome sequencing and in silico genome mining reveal the promising metabolic potential in Streptomyces strain CS-7

Genome Plasticity and Systems Evolution in Streptomyces

Proteomining-Based Elucidation of Natural Product Biosynthetic Pathways in <i>Streptomyces</i>

Complete Genome Sequencing And Antibiotics Biosynthesis Analysis Of Streptomyces Lydicus 103

Complete genome sequencing and antibiotics biosynthesis pathways analysis of Streptomyces lydicus 103

Comparative Genomic Insights into Secondary Metabolism Biosynthetic Gene Cluster Distributions of Marine Streptomyces

Challenging old microbiological treasures for natural compound biosynthesis capacity

Large-Scale Transposition Mutagenesis of Streptomyces Coelicolor Identifies Hundreds of Genes Influencing Antibiotic Biosynthesis

Genome-Guided Exploration Of Streptomyces Ambofaciens Secondary Metabolism

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

Exploration of Diverse Secondary Metabolites From Streptomyces sp. YINM00001, Using Genome Mining and One Strain Many Compounds Approach

Unexpected genomic, biosynthetic and species diversity of Streptomyces bacteria from bats in Arizona and New Mexico, USA

Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes

Genome-Wide Analysis Reveals The Secondary Metabolome In Streptomyces Kanasensis Zx01

Comparative genomics studies provide insights into the taxonomic classification and secondary metabolic potential of five bioactive Streptomyces species isolated from the North-Western Himalaya

Genome Mining of Streptomyces Sp. YIM 130001 Isolated from Lichen Affords New Thiopeptide Antibiotic